Share this article
Share this article
ST. JOSEPH, Mo., April 6, 2021 /PRNewswire/ Boehringer Ingelheim has transitioned to renewable energy to power its largest U.S. manufacturing site, in St. Joseph, Mo., as part of a broader company commitment to environmental sustainability in the United States and around the world.
Wind energy now provides all electricity used at the site, where Boehringer Ingelheim employs nearly 1,000 people who manufacture vaccines for horses, pigs, cattle and other animals. Boehringer Ingelheim and its predecessor companies have manufactured animal health products in St. Joseph for more than a century.
Cimarron Bend Wind Farm in Clark County, Kansas is supplying the energy to Boehringer Ingelheim s manufacturing site in St. Joseph, Missouri.
Share this article
DULUTH, Ga., Jan. 13, 2021 /PRNewswire/
Boehringer Ingelheim Animal Health, a leading provider of medicine for pets, horses and livestock, announced today the appointment of Randolph Legg as its U.S. President. He succeeds Everett Hoekstra, who retired in December.
Legg will remain head of the Company s U.S. commercial business while serving as president.
(PRNewsfoto/Boehringer Ingelheim, Inc.) It s my honor to lead an organization dedicated to enhancing the well-being of people and animals, he said.
Legg held various commercial leadership roles in Boehringer Ingelheim s Human Pharmaceutical division before moving to the company s Animal Health business in 2019 to lead the U.S. Pets Commercial team. He is based at the U.S. headquarters of Boehringer Ingelheim Animal Health in Duluth, Ga.